Radient Pharmaceuticals Corporation fka RXPC

[GetSeriousOK]

Here is what I believe.

-> RXPC stock will never trade again.

-> Radient Pharmaceuticals will never be an active corporation in the USA again.

What else matters?

Who cares what Provista or GCDx does (or doesn't do)? Nothing they do or plan to do has any effect on RXPC shares or Radient Pharmaceuticals. In the remote chance that Provista ever does anything with DR-70, it will be off patent and therefore will not benefit RXPC ex-shareholders in any way.

Who cares what UNI does (or doesn't do)? Their Radient Agreement terminated last year.

And since the discussion keeps drifting to GCDX for some reason, here is what I believe about GCDx.

-> The test being marketed (notice I did not say "sold" because I doubt they are selling much if any) is just the same old failed DR-70 that was marketed by Radient Pharmaceuticals from 1995-2014 and is now off patent.

-> GCDx will never turn a profit from selling this test because DR-70 has no support from the Medical Community or Government and there is ZERO chance that DR-70 will ever be cleared by the FDA as a cancer screener. Radient couldn't get it cleared for anything other than MONITORING CRC and only then when used in conjunction with CEA.

-> GCDx is getting their specificity / sensitivity numbers from Radient's old studies and trials. They won't make their white paper or trial/study results available -- I believe this is because they never did their own trials or studies.

-> Since DR-70 is off patent, if there was money to be made, someone with funding (like JnJ or GSK) would market DR-70 and crush GCDx. The fact that nobody else in the US wants to market DR-70 says it all.